| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000023886 |
| Receipt No. | R000027482 |
| Official scientific title of the study | The association between acotiamide hydrochloride hydrate and bacteriostasis of H. pylori in H. pylori-positive patients with functional dyspepsia -open labeled study- |
| Date of disclosure of the study information | 2016/09/01 |
| Last modified on | 2018/02/22 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | The association between acotiamide hydrochloride hydrate and bacteriostasis of H. pylori in H. pylori-positive patients with functional dyspepsia -open labeled study- | |
| Title of the study (Brief title) | The association between acotiamide hydrochloride hydrate and bacteriostasis of H. pylori in H. pylori-positive patients with functional dyspepsia -open labeled study- | |
| Region |
|
|
| Condition | ||
| Condition | Functional dyspepsia
Helicobacter pylori infection |
|
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To examine influence of the urase activity by H. pylori on acotiamide hydrochloride hydrate |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The change of urea breath test by taking acotiamide hydrochloride hydrate |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | bacteriostatic of H. pylori by acotiamide hydrochloride hydrate | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | (1) The patients that suffer from fullness after meal, fullness at epigastrium or early satiety for more than one month
(2) In F scale, the score about Postprandial Distress Syndrome (PDS) is more than three points (The frequency of the symptom is more often). (3) the patients who examined esophagogastroduodenography in the past 6 months and have no organic disease in stomach. (4) Helicobacter pylori positive (5) Patients who are older than 20 years old and less than 80 years old. (6) Outpatients (7) Patients from whom written informed consent is obtained. |
|||
| Key exclusion criteria | (1) Chief complain is heartburn or epigastric pain
(2) The patients who have recieved the treatment of irritable bowel syndrome. (3) The patients who have taken proton pump inhibitor, antibacterial agent, antiprotozoal agent, bismuth preparation, or ecabet sodium in the past 2 weeks. (4) Severe drug allergy (5) The pregnant, the lactating woman, or the patient hoping pregnancy. (6) acotiamide allergy (7) Patients who are judged as being inappropriate for this study by their medical doctor |
|||
| Target sample size | 30 | |||
| Research contact person | |
| Name of lead principal investigator | Kazunari Murakami |
| Organization | Oita university |
| Division name | Department of Gastroenterology |
| Address | 1-1, Idaigaoka, Hasama, Yufu, Oita, 879-5593, Japan |
| TEL | 097-586-6193 |
| murakam@oita-u.ac.jp | |
| Public contact | |
| Name of contact person | Kazuhiro Mizukami |
| Organization | Oita university |
| Division name | Department of Gastroenterology |
| Address | 1-1, Idaigaoka, Hasama, Yufu, Oita, 879-5593, Oita, Japan |
| TEL | 097-586-6193 |
| Homepage URL | |
| mizkaz0809@oita-u.ac.jp | |
| Sponsor | |
| Institute | Oita university |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Astellas Pharma Inc., and Zeria Pharmaceutical Co., Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | Takada Chuo Hospital |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027482 |